CLINICAL_TRIALS
trial_result
· 2012-11-28
Clinical Trial Update: Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer [Phase 2]
Summary
Phase 2 trial investigating sorafenib in patients with refractory non-small cell lung cancer has completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eastern Cooperative Oncology Group | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-11-28